van Agtmaal J, van Hoogstraten S, Arts J
J Funct Biomater. 2024; 15(10).
PMID: 39452605
PMC: 11508679.
DOI: 10.3390/jfb15100307.
Gil-Gil T, Berryhill B
bioRxiv. 2024; .
PMID: 39282318
PMC: 11398456.
DOI: 10.1101/2024.09.06.611640.
Berryhill B, Gil-Gil T, Witzany C, Goldberg D, Vega N, Regoes R
bioRxiv. 2024; .
PMID: 39229007
PMC: 11370618.
DOI: 10.1101/2024.08.23.609294.
Wu Y, Li G, Tang H
Int J Mol Sci. 2024; 25(16).
PMID: 39201552
PMC: 11354627.
DOI: 10.3390/ijms25168866.
Ledger E, Edwards A
mBio. 2024; 15(8):e0164324.
PMID: 39041819
PMC: 11323798.
DOI: 10.1128/mbio.01643-24.
The Interplay between Antibiotics and the Host Immune Response in Sepsis: From Basic Mechanisms to Clinical Considerations: A Comprehensive Narrative Review.
Tosi M, Coloretti I, Meschiari M, De Biasi S, Girardis M, Busani S
Antibiotics (Basel). 2024; 13(5).
PMID: 38786135
PMC: 11117367.
DOI: 10.3390/antibiotics13050406.
Measuring beta-lactam minimum inhibitory concentrations in in the clinical microbiology laboratory: pinning the tail on the donkey.
Sakoulas G, Nizet V
J Clin Microbiol. 2023; 62(1):e0036623.
PMID: 37966224
PMC: 10793257.
DOI: 10.1128/jcm.00366-23.
Antibiotic Resistance: Challenges and Strategies in Combating Infections.
Chavada J, Muneshwar K, Ghulaxe Y, Wani M, Sarda P, Huse S
Cureus. 2023; 15(9):e46013.
PMID: 37900415
PMC: 10602366.
DOI: 10.7759/cureus.46013.
Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria.
Lennard P, Hiemstra P, Nibbering P
Antibiotics (Basel). 2023; 12(10).
PMID: 37887219
PMC: 10604037.
DOI: 10.3390/antibiotics12101518.
Re-evaluation of FDA-approved antibiotics with increased diagnostic accuracy for assessment of antimicrobial resistance.
Heithoff D, Barnes V L, Mahan S, Fried J, Fitzgibbons L, House J
Cell Rep Med. 2023; 4(5):101023.
PMID: 37116500
PMC: 10213814.
DOI: 10.1016/j.xcrm.2023.101023.
Bi-fluorescent infection enables single-cell analysis of intracellular killing .
Hinman K, Laforce-Nesbitt S, Cohen J, Mundy M, Bliss J, Horswill A
Front Immunol. 2023; 14:1089111.
PMID: 36756129
PMC: 9900177.
DOI: 10.3389/fimmu.2023.1089111.
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace.
Nwobodo D, Ugwu M, Oliseloke Anie C, Al-Ouqaili M, Ikem J, Victor Chigozie U
J Clin Lab Anal. 2022; 36(9):e24655.
PMID: 35949048
PMC: 9459344.
DOI: 10.1002/jcla.24655.
Proteomic Correlates of Enhanced Daptomycin Activity following β-Lactam Preconditioning in Daptomycin-Resistant, Methicillin-Resistant Staphylococcus aureus.
Lew C, Pellitteri Hahn M, Scarlett C, Rottier A, Berti A, Proctor R
Antimicrob Agents Chemother. 2022; 66(3):e0201721.
PMID: 35041502
PMC: 8923230.
DOI: 10.1128/AAC.02017-21.
Rapid resistance development to three antistaphylococcal therapies in antibiotic-tolerant staphylococcus aureus bacteremia.
Miller C, Monk J, Szubin R, Berti A
PLoS One. 2021; 16(10):e0258592.
PMID: 34669727
PMC: 8528304.
DOI: 10.1371/journal.pone.0258592.
Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?.
Park H, Lee W, Shin M, Shin S
Front Immunol. 2021; 12:703060.
PMID: 34262571
PMC: 8273550.
DOI: 10.3389/fimmu.2021.703060.
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.
Redhead M, Owen C, Brewitz L, Collette A, Lukacik P, Strain-Damerell C
Sci Rep. 2021; 11(1):13208.
PMID: 34168183
PMC: 8225628.
DOI: 10.1038/s41598-021-92416-4.
Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing in Animal Infection Models: a Current State of Affairs.
Asempa T, Abdelraouf K, Nicolau D
Antimicrob Agents Chemother. 2021; 65(6).
PMID: 33782001
PMC: 8315912.
DOI: 10.1128/AAC.02271-20.